Bloomberg

News Opinion Markets Personal Finance Tech Politics Sustainability TV Video Radio

BGov Briefs

Matthew Barry




Inside Sanofi-Aventis Production Site

An employee inspects a sample of pills at a Sanofi-Aventis SA factory in Compiegne, France, on Friday, Oct. 8, 2010. Sanofi-Aventis SA's three-month effort to acquire Genzyme Corp. took a more contentious turn as the companies' chief executive officers offered conflicting accounts of their face-to-face meeting last month. Photographer: Antoine Antoniol/Bloomberg

Drugmakers’ Paranoia May Be Due to Politicians Chasing Them

Drugmakers made $80 billion in concessions as part of passage of the Affordable Care Act. Politicians may be coming back for now as part of deficit reduction.

Read more »